Amy Jacob

Magnetic resonance is an effective alternative to biopsy for identifying and quantifying fats in the liver, according to results from a study led by a research team at the University of the Basque Country.

Reports suggest that combination therapy with the drug afamelanotide and narrowband ultraviolet-B ray (NB UVB) phototherapy is safe and effective for restoring skin pigmentation in patients with vitiligo, a skin disease resulting from dead melanin-producing cells with no current cure.

Experts have discovered a possible correlation between treatment with isotretinoin and decreased risk of inflammatory bowel disease, according to a study published in the Journal of American Medical Association Dermatology.

Researchers at Beth Israel Deaconess Medical Center (BIDMC) reported that proactive monitoring of dose adjustments of infliximab (IFX), one of the 4 anti-TNF-alpha proteins used to treat inflammatory diseases like Crohn's disease (CD), ulcerative colitis (UC), and inflammatory bowel disease (IBD), could prolong the effectiveness of treatment.

Paul Wicks, PhD, comments on physicians' acceptance of technological evolution in data collection at the 2014 Joint ACTRIMS-ECTRIMS Meeting in Boston.

Nancy Chiaravalloti, PhD, shares how cognitive function impacts patients with progressive multiple sclerosis at the 2014 Joint ACTRIMS-ECTRIMS Meeting in Boston.

As reported in the EMBO Molecular Medicine journal, researchers have discovered there are several types of dendritic cells within human skin that play a role in both the earlier and more advances stages of psoriasis.

Don Mahad, MD, PhD, discusses his research's focus of protecting nerve cells at the 2014 Joint ACTRIMS-ECTRIMS Meeting in Boston.

Alasdair Coles, MD, University of Cambridge, shares his thoughts on the efficacy of alemtuzumab for patients with multiple sclerosis (MS) at the 2014 Joint ACTRIMS-ECTRIMS Meeting in Boston.

Mikkel Anthonisan, MD, highlights his experience as the founder of Oceans of Hope, a global voyage to change the perception of multiple sclerosis, at the 2014 Joint ACTRIMS-ECTRIMS Meeting.

Breast feeding can potentially protect premature babies from a toxic gastrointestinal disease, according to a recent study published in in the American Journal of Pathology.

Investigators have found that many autoimmune diseases are implicated in the surge and development of eating disorders, according to a study published in PLoS One.

A recent study published in Clinical Gastroenterology and Hepatology cites the efficacy and safety of resuming infliximab therapy for inflammatory bowel disease (IBD) patients following a drug holiday.

Neon feces could prove to be a game changer in gastrointestinal cancer testing. Researchers at McMaster University, Hamilton, Ontario, Canada, are developing a new non-invasive stool exam to identify the presence of colorectal cancer.

According to researchers at the Stanford University School of Medicine, an ultraviolet light-induced genetic mutation is the probable culprit fueling countless human skin cancers.

A new study published in the Journal of Clinical Pharmacology suggests poor stomach absorption could potentially decrease the efficacy of autism drugs.

A research team with members at the University of California, Los Angeles (UCLA) has discovered genetic factors involved in a severe form of inflammatory bowel disease (IBS), pediatric ulcerative colitis.

Psoriasis, plaguing patients with its seemingly incurable symptoms, may have met its match. Skylit Medical, a startup in San Diego, is developing a phototherapy device to use as treatment for psoriasis as well as eczema and vitiligo.

Researchers at the University of Leicester have developed a highly sensitive "electronic-nose" to identify the infectious bacteria Clostridium difficile that causes diarrhea, stomach cramps, and fever in patients.

Monitoring patients' own intestinal immune responses, researchers at Yale University have identified some of the bacterial culprits driving inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis.

Gastroparesis, or delayed gastric emptying, remains misunderstood despite rising prevalence, according to a news release from the International Foundation for Functional Gastrointestinal Disorders (IFFGD), a nonprofit research and education organization addressing issues surrounding gastrointestinal and motility disorders.

A new multi-step skin testing protocol effectively determines the presence of isosulfan blue allergy, according to a study conducted by researchers at the University of Virginia.

With more people than ever using cell phones, tablets, and other personal technological devices, dermatologists have voiced concerns over the increase in cases of nickel allergies. Nickel, one of the most prevalent allergens in the United States, can be found within most handheld electronic devices and jewelry.

Insulin, a peptide hormone, can protect the cells of the pancreas from acute pancreatitis – a disease for which there is currently no cure, according to a study by scientists from The University of Manchester.

Widely known to prevent signs of aging, injections of Botox (onabotulinumtoxinA) could also be used to sever nerves to halt tumor growth in gastrointestinal cancer

Researchers have made several impressive advances in gastrointestinal medicine in recent years, including the use of fecal microbiota transplantation (FMT) to treat recurrent Clostridium difficile infection. Following the success of that approach, researchers have been evaluating FMT for the treatment of other conditions, with one team recently conducting the first randomized controlled trial of FMT to treat inflammatory bowel disease (IBD).

Many control psoriasis-ridden skin only to find traces of discolored patches in its wake. A study by the Milstein Medical Research Program at The Rockefeller University has uncovered the correlation between skin discoloration and psoriasis, providing opportunities of treatment for pigmentation changes within eczema and acne as well.